💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for AxoGen, Inc. (AXGN)
« Back to company indexAXGN Chatter Timeline
Stock Ticker for AXGN
Most Active Tweeters for AXGN
| User | Tweets |
|---|---|
| @Tickeron | 4 |
| @AlertTrade | 3 |
| @ShortAlgoTrades | 3 |
| @ChartMill | 2 |
| @newsfilterio | 1 |
Recent Tweets for AXGN
 |
@newsfilterio $468,756.25 of shares acquired by Zaderej Karen L. (CEO), reported in a new form 4 filed with the SEC $AXGN https://t.co/izl6NpK10w November 30th 2021, 6:11am |
 |
@Tickeron $AXGN's Aroon indicator drops into Downtrend on November 8, 2021. View odds for this and other indicators:… https://t.co/Htxd16jRZx November 27th 2021, 8:11pm |
 |
@kwhenfinance Axogen Inc. Shares Close in on 52-Week Low - Market Mover https://t.co/g0a4KP7JQm $AXGN #stockmarket #kwhenfinance November 27th 2021, 1:11pm |
|
@Tickeron $AXGN in Downtrend: RSI indicator stops in oversold zone for 8 days. View odds for this and other indicators:… https://t.co/BiXQnSRN6x November 27th 2021, 2:11am |
|
@Tickeron A.I.dvisor made a bearish call on $AXGN, netting in a 20.36% gain over 7 days #Axogen #stockmarket #stock… https://t.co/4iVNrq23P6 November 26th 2021, 11:11pm |
|
@Tickeron A.I.dvisor made a bearish call on $AXGN, netting in a 26.27% gain over 1 week #Axogen #stockmarket #stock… https://t.co/HRG18y4HrP November 26th 2021, 9:11pm |
 |
@ShortAlgoTrades $AXGN Awaiting BUY signal on AXGN with https://t.co/Mh6eu0SSsA https://t.co/u0IlnlyoH1 November 25th 2021, 11:11pm |
|
@ShortAlgoTrades $AXGN waiting for buy signal on AXGN https://t.co/FAXKhsi0jI November 25th 2021, 1:11pm |
 |
@AlertTrade RT @AlertTrade: UPSIDE MOMO: $AXGN Axogen, Inc. ? TradeIdeas via ? https://t.co/VS8RO1bzXJ November 23rd 2021, 7:11pm |
|
@AlertTrade UPSIDE MOMO: $AXGN Axogen, Inc. ? TradeIdeas via ? https://t.co/VS8RO1bzXJ November 23rd 2021, 7:11pm |
|
@ShortAlgoTrades $AXGN Waiting for buy signal on AXGN https://t.co/mK9Opea67c November 23rd 2021, 3:11pm |
 |
@ChartMill $AXGN was analyzed by 13 analysts. The buy consensus is at 83%. So analysts seem to be very confident about $AXGN.… https://t.co/Zx5rHvHGKZ November 23rd 2021, 3:11am |
|
@AlertTrade MOST ACTIVE: $AXGN Axogen, Inc. ? TradeIdeas via ? https://t.co/VS8RO1bzXJ November 22nd 2021, 7:11pm |
 |
@invescent $AXGN Data indicates that the overall analyst sentiment for AXGN is bearish. Simplify the way you research stock… https://t.co/ntntd6mXaU November 22nd 2021, 9:11am |
|
@ChartMill $AXGN shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 18.85%.… https://t.co/9eqzdAL7Yq November 20th 2021, 3:11pm |
|
@AlertTrade SOCIAL ACTIVITY: $AXGN - Axogen, Inc. https://t.co/Zf690QyK9O ? TradeIdeas via ? https://t.co/VS8RO1bzXJ November 19th 2021, 6:11pm |
 |
@PaulTorresCohen Paul Torres-Cohen $AXGN November 18th 2021, 8:11pm |
 |
@SweepCastApp SweepCast alerted: $AXGN with Unusual Options Activity Alerted on $17.5 CALL Expiring: 01-21-2022 worth 45K? |? Sta… https://t.co/JKjWc2dbah November 17th 2021, 11:11pm |
 |
@SwingTradeBot New 52 Week Low today: $AXGN $AIM ... https://t.co/0EM4q8YtyQ November 17th 2021, 5:11pm |
 |
@42sBandit SOLD: At the open I sold $AXGN for a loss of -19.4% after holding for 10 trading days (-1.94% per day). https://t.co/q2mReRJfzG November 15th 2021, 2:11pm |
|
@Tickeron $AXGN's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram just turned negative. View odds for th… https://t.co/PVm4S9DmBS November 15th 2021, 2:11am |
|
@ChartMill $AXGN was analyzed by 13 analysts. The buy consensus is at 83%. So analysts seem to be very confident about $AXGN.… https://t.co/EgKatlthDb November 14th 2021, 11:11pm |
 |
@LargeVoidBot 12:21 New 52wk Lows: $AXGN November 12th 2021, 5:11pm |
 |
@shortablestocks Zero shares available to short currently in $AXGN. https://t.co/qKJcOuthXP https://t.co/s5ZtUC7SQ6 November 11th 2021, 4:11pm |
 |
@StockNewsBot2 $AXGN Axogen, Inc. to Participate at Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services F… https://t.co/YyeaHTiHcY November 10th 2021, 12:11pm |
 |
@stock_titan $AXGN Axogen, Inc. to Participate at Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services F… https://t.co/R3upJ2vWoy November 10th 2021, 12:11pm |
 |
@thegoodprick @BobbyKKraft My thesis is: if a chart like $axgn is "real" what is the implication seeing something similar in… https://t.co/CVhQ7ucMfy November 9th 2021, 11:11pm |
|
@thegoodprick @BobbyKKraft @AltaFoxCapital see tweet on $axgn November 9th 2021, 11:11pm |
|
@42sBandit RT @42Stocks: https://t.co/T2j9GsDTez 2021-NOV-08 10:05am $AXGN #axogen up 3.71% = $21.1 million gain. https://t.co/UjGnzWKPe9 November 8th 2021, 3:11pm |
 |
@42Stocks https://t.co/T2j9GsDTez 2021-NOV-08 10:05am $AXGN #axogen up 3.71% = $21.1 million gain. https://t.co/UjGnzWKPe9 November 8th 2021, 3:11pm |
|
@Tickeron $AXGN in Uptrend: price may jump up because it broke its lower Bollinger Band on November 4, 2021. View odds for th… https://t.co/FmQp9U6sqD November 7th 2021, 10:11pm |
|
@Tickeron $AXGN in Uptrend: price expected to rise as it breaks its lower Bollinger Band on November 4, 2021. View odds for t… https://t.co/ya8RNRhMSt November 7th 2021, 3:11am |
|
@42sBandit RT @42Stocks: https://t.co/T2j9GsDTez 2021-NOV-05 12:00pm $AXGN #axogen up 5.75% = $37.1 million gain. https://t.co/HtrqhZsHI9 November 5th 2021, 4:11pm |
|
@42Stocks https://t.co/T2j9GsDTez 2021-NOV-05 12:00pm $AXGN #axogen up 5.75% = $37.1 million gain. https://t.co/HtrqhZsHI9 November 5th 2021, 4:11pm |
|
@shortablestocks $AXGN is short sale restricted for 2021-11-05. https://t.co/qKJcOuthXP November 5th 2021, 1:11pm |
|
@ShortAlgoTrades $AXGN Awaiting Buy Signal. Stock Trading Ideas by https://t.co/jpmUt7BvVp https://t.co/nyiJNDsxTB November 4th 2021, 7:11pm |
 |
@SismasStock $AXGN waiting for Buy signal on AXGN https://t.co/c0iQQT8kIP November 4th 2021, 5:11pm |
 |
@SmallCapsDaily $AXGN Axogen, Inc. to Participate at Jefferies London Healthcare Conference GlobeNewswire -17.72%… https://t.co/jFAm2H047F November 4th 2021, 3:11pm |
 |
@Jarvis_Alerts $AXGN [Axogen]: JMP Securities Maintains Market Outperform Lowers Price Target $25 --> 20 Sign-up free for beta v… https://t.co/9NrD1uB0Ue November 4th 2021, 3:11pm |
 |
@mehabecapital Stocks in Top Losers today: $AXGN, Current Price: $13.52, Change today: -18.62%, Total Traded Volume: 115953 https://t.co/vCmZw5VBNT November 4th 2021, 2:11pm |
|
@AlertTrade DOWNSIDE MOMO: $AXGN Axogen, Inc. ? TradeIdeas via ? https://t.co/VS8RO1bzXJ November 4th 2021, 2:11pm |
|
@LargeVoidBot 10:00 New 52wk Lows: $AXGN $CLVR November 4th 2021, 2:11pm |
 |
@quantisnow $AXGN ? JMP Securities reiterated coverage on Axogen with a new price target https://t.co/PYziW59Vkj 30 seconds delayed. November 4th 2021, 1:11pm |
|
@StockNewsBot2 $AXGN Axogen, Inc. to Participate at Jefferies London Healthcare Conference https://t.co/BvV8j5pFqc November 4th 2021, 11:11am |
|
@quantisnow $AXGN ? Axogen, Inc. to Participate at Jefferies London Healthcare Conference https://t.co/Y3QnF9O0X7 30 seconds delayed. November 4th 2021, 11:11am |
|
@stock_titan $AXGN Axogen, Inc. to Participate at Jefferies London Healthcare Conference https://t.co/6YUfiPWIqw November 4th 2021, 11:11am |
 |
@EarningsAlley AxoGen, Inc. $AXGN held an earnings call on 11/3/2021. Here are the highlights: November 4th 2021, 1:11am |
 |
@StckPro $AXGN NEW ARTICLE : AxoGen's (AXGN) CEO Karen Zaderej on Q3 2021 Results - Earnings Call Transcript… https://t.co/F9bmWwhoyg November 4th 2021, 1:11am |
 |
@SeekingAlpha $AXGN - AxoGen's (AXGN) CEO Karen Zaderej on Q3 2021 Results - Earnings Call Transcript. https://t.co/qeAeCp9QGB… https://t.co/nwaIp6e6jc November 4th 2021, 1:11am |
|
@StckPro $AXGN NEW ARTICLE : Axogen: Q3 Earnings Insights https://t.co/BFIrlq8U8S Get all the latest $AXGN related news here… https://t.co/FUkyqTRymy November 3rd 2021, 8:11pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2021. All rights reserved.
DrugPatentWatch Video Training
Decision-making for generic drug entry and branded drug lifecycle management
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
This course answers the following questions to help you adapt:
- ✓ When will key drug patents expire?
- ✓ How can I find, evaluate, and plan for generic market entry opportunities?
- ✓ How can I find proprietary out-of-court settlements and deal terms?